Answers are grounded in this paper and cite their sources.
Stereotypic behavior is a significant welfare concern in captive nonhuman primates, and selective serotonin reuptake inhibitors have shown promise in rhesus macaques (Macaca mulatta). However, evidence of their efficacy in cynomolgus monkeys (Macaca fascicularis) remains limited. This study evaluated the efficacy and tolerability of orally administered fluoxetine in non-naïve cynomolgus monkeys with pre-existing, non-experimentally induced stereotypic behavior. Eight male cynomolgus monkeys were allocated to receive fluoxetine (2 mg/kg orally, once daily for 28 days; n = 4) or placebo (n = 4). Abnormal behavior was scored daily, and body weight, complete blood count, serum biochemistry parameters, and cortisol were monitored. The fluoxetine group showed approximately an 83.8% reduction in mean abnormal behavior score from Week 1 to Week 5, compared with 2.5% in the placebo group. Three of four fluoxetine-treated animals exhibited near-complete behavioral stabilization. Cortisol levels showed a modest downward trend in the fluoxetine group (−12.2%), whereas the placebo group showed high inter-individual variability. No treatment-related mortality or clinically overt adverse effects on monitored health parameters were observed. The findings support fluoxetine at 2 mg/kg as a potential component of multimodal welfare management for captive cynomolgus monkeys with pre-existing stereotypic behaviors, consistent with the Refinement principle of the 3Rs.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: